Wugen, Inc.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Holding
- Established
- 2018-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.wugen.com
A Phase 2 Study WU-CART-007 in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-23
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Wugen, Inc.
- Target Recruit Count
- 125
- Registration Number
- NCT06514794
A Phase 1b Study of WU-NK-101 in Combination With Cetuximab
- First Posted Date
- 2023-01-06
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Wugen, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT05674526
- Locations
- ๐บ๐ธ
UCSF, San Francisco, California, United States
๐บ๐ธMontefiore Medical Center, Bronx, New York, United States
๐บ๐ธCarolina BioOncology, Huntersville, North Carolina, United States
A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007
- First Posted Date
- 2022-08-22
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Wugen, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT05509855
- Locations
- ๐ฆ๐บ
Peter MacCullam Cancer Center, Melbourne, Australia
๐บ๐ธCity of Hope, Duarte, California, United States
๐บ๐ธChildrens Hospital LA, Los Angeles, California, United States
A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)
- First Posted Date
- 2022-07-22
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Wugen, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT05470140
- Locations
- ๐บ๐ธ
Providence Portland Medical Center, Portland, Oregon, United States
๐บ๐ธCity of Hope, Duarte, California, United States
๐บ๐ธUniversity of Maryland, Baltimore, Maryland, United States
A Phase 1/2 Study of the Safety and Efficacy of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-07-30
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Wugen, Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT04984356
- Locations
- ๐บ๐ธ
Children's Hospital Los Angeles, Los Angeles, California, United States
๐ฆ๐บPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia
๐บ๐ธChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath